Overview:

Summary

GlobalData's clinical trial report, “Dyslipidemia Global Clinical Trials Review, Q1, 2011"" provides data on the Dyslipidemia   clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dyslipidemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dyslipidemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Dyslipidemia 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Unaccomplished Trials of Dyslipidemia 21
Subjects Recruited Over a Period of Time 23
Prominent Sponsors 24
Top Companies Participating in Dyslipidemia Therapeutics Clinical Trials 26
Prominent Drug Comparison 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Pfizer Inc. 29
Clinical Trial Overview of Pfizer Inc. 29
Merck & Co., Inc. 31
Clinical Trial Overview of Merck & Co., Inc. 31
AstraZeneca PLC 33
Clinical Trial Overview of AstraZeneca PLC 33
Abbott Laboratories 35
Clinical Trial Overview of Abbott Laboratories 35
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
Sanofi-Aventis 38
Clinical Trial Overview of Sanofi-Aventis 38
Kowa Research Europe Ltd 39
Clinical Trial Overview of Kowa Research Europe Ltd 39
Japan Tobacco Inc. 40
Clinical Trial Overview of Japan Tobacco Inc. 40
GlaxoSmithKline plc 41
Clinical Trial Overview of GlaxoSmithKline plc 41
Bristol-Myers Squibb Company 42
Clinical Trial Overview of Bristol-Myers Squibb Company 42
Cadila Pharmaceuticals Ltd. 43
Clinical Trial Overview of Cadila Pharmaceuticals Ltd. 43
Kowa Research Institute, Inc. 44
Clinical Trial Overview of Kowa Research Institute, Inc. 44
Shionogi & Co., Ltd. 45
Clinical Trial Overview of Shionogi & Co., Ltd. 45
Genzyme Corporation 46
Clinical Trial Overview of Genzyme Corporation 46
F. Hoffmann-La Roche Ltd. 47
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 47
Eli Lilly and Company 48
Clinical Trial Overview of Eli Lilly and Company 48
Biocon Limited 49
Clinical Trial Overview of Biocon Limited 49
Takeda Pharmaceutical Company Limited 50
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 50
Esperion Therapeutics, Inc. 51
Clinical Trial Overview of Esperion Therapeutics, Inc. 51
Mitsubishi Tanabe Pharma Corporation 52
Clinical Trial Overview of Mitsubishi Tanabe Pharma Corporation 52
Clinical Trial Overview of Top Universities / Institutes / Hospitals 53
Kyoto University 53
Clinical Trial Overview of Kyoto University 53
Children's Hospital & Research Center Oakland 54
Clinical Trial Overview of Children's Hospital & Research Center Oakland 54
Queen's University 55
Clinical Trial Overview of Queen's University 55
University of Colorado 56
Clinical Trial Overview of University of Colorado 56
Hiroshima University Hospital 57
Clinical Trial Overview of Hiroshima University Hospital 57
Taipei Veterans General Hospital 58
Clinical Trial Overview of Taipei Veterans General Hospital 58
The University of Utah 59
Clinical Trial Overview of The University of Utah 59
University of Fukui 60
Clinical Trial Overview of University of Fukui 60
Haukeland University Hospital 61
Clinical Trial Overview of Haukeland University Hospital 61
Sheba Medical Center 62
Clinical Trial Overview of Sheba Medical Center 62
University of Washington 63
Clinical Trial Overview of University of Washington 63
Medical University of Vienna 64
Clinical Trial Overview of Medical University of Vienna 64
All India Institute of Medical Sciences 65
Clinical Trial Overview of All India Institute of Medical Sciences 65
Leiden University Medical Center 66
Clinical Trial Overview of Leiden University Medical Center 66
University Hospital Basel 67
Clinical Trial Overview of University Hospital Basel 67
University of Pennsylvania 68
Clinical Trial Overview of University of Pennsylvania 68
Stanford University 69
Clinical Trial Overview of Stanford University 69
Lawson Health Research Institute 70
Clinical Trial Overview of Lawson Health Research Institute 70
Norwegian University of Science and Technology 71
Clinical Trial Overview of Norwegian University of Science and Technology 71
Vanderbilt University 72
Clinical Trial Overview of Vanderbilt University 72
Appendix 73
Abbreviations 73
Definitions 73
Research Methodology 74
Secondary Research 75
About GlobalData 75
Contact Us 76
Disclaimer 76
Source 76"

List of Tables
Dyslipidemia Therapeutics Market, Global, Clinical Trials by Zone, 2011* 8
Dyslipidemia Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 10
Dyslipidemia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 11
Dyslipidemia Therapeutics Clinical Trials, Asia-Pacific , Top Five Countries, 2011* 12
Dyslipidemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2011* 13
Dyslipidemia Therapeutics Clinical Trials, North America, Top Countries, 2011* 14
Dyslipidemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011* 15
Dyslipidemia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2011* 16
Dyslipidemia Therapeutics Clinical Trials, BRIC Countries, 2011* 17
Dyslipidemia Therapeutics Market, Global, Clinical Trials by Phase, 2011* 18
Dyslipidemia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011* 19
Dyslipidemia Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 20
Dyslipidemia Therapeutics Market, Global, Withdrawn Clinical Trials, 2011* 21
Dyslipidemia Therapeutics Market, Global, Terminated Clinical Trials, 2011* 22
Dyslipidemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 23
Dyslipidemia Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 25
Dyslipidemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 27
Dyslipidemia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 28
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011* 29
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2011* 31
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2011* 33
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2011* 35
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2011* 37
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi-Aventis, 2011* 38
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa Research Europe Ltd, 2011* 39
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Tobacco Inc., 2011* 40
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2011* 41
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2011* 42
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cadila Pharmaceuticals Ltd., 2011* 43
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa Research Institute, Inc., 2011* 44
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Shionogi & Co., Ltd., 2011* 45
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2011* 46
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2011* 47
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2011* 48
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Biocon Limited, 2011* 49
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2011* 50
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Esperion Therapeutics, Inc., 2011* 51
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Tanabe Pharma Corporation, 2011* 52
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2011* 53
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Hospital & Research Center Oakland, 2011* 54
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2011* 55
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2011* 56
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hiroshima University Hospital, 2011* 57
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Taipei Veterans General Hospital, 2011* 58
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Utah, 2011* 59
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Fukui, 2011* 60
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Haukeland University Hospital, 2011* 61
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheba Medical Center, 2011* 62
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2011* 63
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2011* 64
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2011* 65
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2011* 66
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2011* 67
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2011* 68
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2011* 69
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Lawson Health Research Institute, 2011* 70
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Norwegian University of Science and Technology, 2011* 71
Dyslipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2011* 72"

List of Figures
Dyslipidemia Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 8
Dyslipidemia Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 9
Dyslipidemia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 11
Dyslipidemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011* 12
Dyslipidemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011* 13
Dyslipidemia Therapeutics Clinical Trials, North America, Top Countries (%), 2011* 14
Dyslipidemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2011* 15
Dyslipidemia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2011* 16
Dyslipidemia Therapeutics Clinical Trials, BRIC Countries (%), 2011* 17
Dyslipidemia Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 18
Dyslipidemia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011* 19
Dyslipidemia Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 20
Dyslipidemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 23
Dyslipidemia  Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 24
Dyslipidemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 26
Dyslipidemia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 28
GlobalData Methodology 75